NCT00633152 - Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Bacterial Infection

Interventions

DRUG

ceftaroline

600 mg injected every 12 hours for at least 5 but not more than 14 days

DRUG

linezolid

600 mg parenteral infused over 60 minutes for a minimum of 5 days and a maximum of 14 days

DRUG

Aztreonam

1000 mg infused over 60 minutes every 24 hours may be started with linezolid or added later (up to 72 hours after the first dose of linezolid) for subjects with a gram-negative infection indicated.

Trial Locations (13)

31405

Investigational Site, Savannah

31904

Investigational Site, Columbus

33462

Investigational Site, Atlantis

43215

Investigational Site, Columbus

43608

Investigational Site, Toledo

55422

Investigational Site, Minneapolis

59701

Investigational Site, Butte

90015

Investigational Site, Los Angeles

90274

Investigational Site, Rolling Hills Estate

90813

Investigational Site, Long Beach

92114

Investigational Site, San Diego

96020

Investigational Site, Buena Park

08244

Investigational Site, Somers Point